Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
NCT00784823
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Bortezomib 1 mg/m2
DRUG:
Bortezomib 1.3 mg/m2
DRUG:
Bortezomib 1.6 mg/m2
DRUG:
Melphalan
Sponsor
Hackensack Meridian Health